Innovation Pharmaceuticals Inc (IPIX)

[DaubersUP]

Dec 31st 2014 - Share price - $4.40
Cash on hand - 9.4 million
Total OS - 117 Million (ish)
PROGRESS 1) Kevetrin - In Progress Phase 1 - Enrolling in the 10th cohort
2) Prurisol - Successful Phase 1 Completed - Comparing bio-availability b/w P and Ziagen
3) B-Absssi - Successful Phase 2b Completed - Topline data Oct 23rd - full data in 2015 to be announced
4) B-OM - IND filed in Sept 2014 and granted by FDA in Oct 2014 **2 Successful Human Trials to date** https://www.bamsec.com/filing/147793215001033?cik=1355250
Posted in Feb2015 for Q ending Dec 31st 2014

March 31st 2018 - Share price - .52
Cash on hand - 3.3 million
Total OS - 155 Million PROGRESS
1) Kevetrin - Phase 1 Successful (Solid Tumors)
2) Kevetrin - Phase 2 Successful (Ovarian)
3) Prurisol - Phase 2a Successful (Mild - Moderate Psoriasis)
4) Prurisol - Phase 2b Completed (Moderate - Severe Psoriasis) DATA ANY DAY
5) B-OM - Phase 2 Successful (Oral Mucositis - PREVENTION) Leader in an untapped market
6) B-UP/UC - Phase 2 PoC Successful **5 Additional late stage Human trials SUCCESSFUL - Awaiting data on a Phase 2b for Prurisol** So to summarize - in 3.5 years IPIX was able to complete 5 SUCCESSFUL human trials and awaiting on data for a phase 2b. The share count increased by about 38 Million shares

@@@@@@@@@@@@
This is old post but informative.
We have doubles OS count since. I believe. Phase 2 for Prurisol failed. Only failed trial to date.

Covid pre clinical was extremely bullish. We go into trials this week for phase 2

This pipeline is phenomenal. Billions and in late stages across board. So the big question. WHY can’t Leo ink a deal. That is the question we all should be asking him daily. The drugs are too powerful on paper to screw this up. IMO.